[Form 4] Cognizant Technology Solutions Insider Trading Activity

Rhea-AI Filing Summary

Cognizant director Karima Silvent received 12.3818 restricted stock units (RSUs) on 08/26/2025 as dividend equivalents on previously outstanding RSUs. Each RSU represents a contingent right to one share of Class A common stock. The reported transaction did not involve cash consideration and shows a price of $0 per unit.

Following this award, Ms. Silvent beneficially owns 2,875.3818 shares of Class A common stock. The newly granted RSUs will vest fully on June 3, 2026. The Form 4 was signed under power of attorney on 08/28/2025.

Positive

• Non-cash equity award of 12.3818 RSUs received as dividend equivalents, indicating compensation tied to equity
• Clear vesting schedule: RSUs vest fully on June 3, 2026, providing time-based alignment with shareholders
• Beneficial ownership disclosed: total of 2,875.3818 Class A shares reported after the transaction

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received dividend-equivalent RSUs, modestly increasing reported beneficial ownership and tying compensation to long-term equity.

The filing documents a non-cash grant of 12.3818 restricted stock units to a company director, recorded as dividend equivalents on prior RSUs. This increases reported beneficial ownership to 2,875.3818 shares and carries a full vesting date of June 3, 2026. From a governance perspective, equity-based awards that vest over time align director interests with shareholders without immediate dilution via open-market purchases. The disclosure appears routine and transparent; no cash sale or exercise occurred.

Securities Analyst

TL;DR: Insider received a small, time‑vested equity grant; impact on share count and market is negligible.

The Form 4 reports 12.3818 RSUs granted as dividend equivalents, priced at $0, and increasing beneficial ownership to 2,875.3818 shares. The award vests on June 3, 2026. For investors assessing insider activity, this is a standard compensation-related grant rather than a purchase or sale. The transaction does not indicate liquidity events or immediate changes in voting power beyond the incremental units disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silvent Karima

(Last) (First) (Middle)

C/O COGNIZANT TECHNOLOGY SOLUTIONS CORP.

300 FRANK W. BURR BLVD., STE. 36, 6 FL.

(Street)

TEANECK NJ 07666

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNIZANT TECHNOLOGY SOLUTIONS CORP [ CTSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/26/2025		A(1)		12.3818		(2)	(2)	Class A Common Stock	12.3818	$0	2,875.3818	D

Explanation of Responses:

1. Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company.

2. The restricted stock units will vest fully on June 3, 2026.

Remarks:

	/s/ Kelli Arman, on behalf of Karima Silvent, by Power of Attorney	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Karima Silvent report on Form 4 for CTSH?

The filing reports receipt of 12.3818 restricted stock units as dividend equivalents on 08/26/2025, increasing her beneficial ownership to 2,875.3818 shares.

Were any shares purchased or sold by the insider in this Form 4?

No. The transaction was an award of RSUs with a reported price of $0, not a market purchase or sale.

When do the newly reported RSUs vest?

The restricted stock units will vest fully on June 3, 2026.

Does the Form 4 indicate any change in control or large disposition?

No. The filing documents a routine equity grant to a director and does not disclose any change in control or material disposition.

Who signed the Form 4 on behalf of the reporting person?

The Form 4 was signed by Kelli Arman on behalf of Karima Silvent by power of attorney on 08/28/2025.